638. Are You Ready for the Elder Swell?

Episode Summary

Executive Summary: The episode frames aging as an “elder swell”: a historic demographic shift driven by lower fertility and longer, healthier lives. It combines history, economics, and biotech to argue that societies should stop treating old age as a burden and instead redesign pensions, healthcare, and work for longer, healthier lifespans, while private longevity startups push innovation faster than government.

Main Topics: The ‘elder swell’ and rising healthspan (Priority: 5/5): Dubner opens with data showing the U.S. and world are aging rapidly, but with better health than past generations. The discussion distinguishes lifespan from healthspan and argues that older adults today are cognitively and physically younger than peers were decades ago. Historical origins of retirement and social protection (Priority: 5/5): Historian James Chappell explains how Social Security, Medicare, and postwar policy created modern retirement. He traces the shift from ad hoc elder support to a state-backed promise that older citizens will be cared for in old age. Andrew Scott’s longevity economics (Priority: 5/5): Economist Andrew Scott argues that aging should be treated as a longevity opportunity rather than a crisis. He proposes age-friendly jobs, lifelong learning, prevention-focused healthcare, and policy tied to healthy life expectancy. Private-sector longevity and biotech startups (Priority: 4/5): The episode explores venture-backed companies like Loyal and BioAge that are trying to extend healthspan in dogs and humans. These firms see longevity as a route to preventative medicine, but face scientific, regulatory, and funding challenges. Retirement, labor markets, and ageism (Priority: 4/5): The conversation highlights that retirement is a recent social invention, not a timeless norm. It also argues that ageism underestimates older workers’ capacity and blocks the labor-market adaptations needed for longer lives. Young people’s perspective on aging (Priority: 3/5): Kyla Scanlon reflects on how a 27-year-old thinks about old age, retirement, and the possibility of living to 100-plus, emphasizing adaptability, learning, and the uncertainty of long-range life planning.

Key Arguments: Lower fertility and major gains in life expectancy have created an unprecedented demographic shift that will soon leave the U.S. with more people 65+ than 18 and younger. The important change is not just that people live longer, but that they stay healthier longer; modern 70-year-olds resemble much younger people from 2000 in physical and cognitive terms. Social Security and Medicare were historically pragmatic responses to old-age insecurity and helped construct modern retirement, but they now need updating rather than retrenchment. Aging should be reframed as a longevity society: policy should support people working longer, staying healthy longer, and transitioning across multiple life stages. Age-friendly jobs, prevention, and healthier aging would be more valuable than simply raising retirement ages without preparing workers. Private biotech is advancing longevity science, but the field is risky, expensive, and heavily constrained by FDA rules because aging is not officially treated as a disease. Public policy should measure and reward healthy life expectancy, not just lifespan or waiting-list metrics, so governments invest in prevention rather than only treatment. Older workers are a major source of employment growth in rich countries, so labor markets must adapt to their skills rather than exclude them. The elder-care economy should be treated as a major, dignified, and regulated part of the economy, not a leftover sector to be staffed precariously.

Data Points: U.S. demographic crossover: Within 10 years, people 65+ will likely outnumber people 18 and younger - Opening framing of the “elder swell” IMF physical age comparison: A modern 70-year-old’s physical condition = a 56-year-old in 2000 - International Monetary Fund study across 41 countries IMF cognitive age comparison: A modern 70-year-old’s cognitive ability = a 53-year-old in 2000 - International Monetary Fund study across 41 countries U.S. life expectancy at birth: About 78.5 years - Current U.S. life expectancy cited in the Chappell segment Female life expectancy: Around 81 years - U.S. estimate cited by James Chappell Male life expectancy: Around 75 years - U.S. estimate cited by James Chappell U.S. life expectancy in 1950: 68.2 years - Historical comparison U.S. life expectancy in 1900: 47 years - Historical comparison Share of older men working in the 1950s: About 60-65% - Chappell on labor force participation before modern retirement Share of older men working by the 1980s: About 20-25% - Chappell on retirement’s rise Social Security workers per beneficiary in 1965: 4 workers per beneficiary - Current scaffolding comparison in the episode Social Security workers per beneficiary now: Less than 3 workers per beneficiary - Shows strain on the system BioAge market cap peak: More than $600 million - Before recent trial setback BioAge market cap later: Around $150 million - After setbacks Loyal funding: Over $125 million - Dog longevity startup funding before later raises Loyal additional funding: Another $22 million - Reported later in the episode Loyal study enrollment: 1,000 dogs - Dogs enrolled to test the longevity drug Aging 2.0 focus: Fastest growing, highest utilizing, most expensive consumers of healthcare - Katie Fike describing the aging market Older-worker GDP estimate: 4% of GDP annually - Andrew Scott’s estimate if the decline in 50-to-65 employment were halved Median/typical death age in UK today: 87 - Andrew Scott on the modal age of death Age-related employment growth in high-income countries: Majority of job growth comes from older workers - Scott cites 60% in the U.S., 75% in the UK, over 100% in Europe Healthcare spending in U.S.: About $4 trillion - Scott response to hypothetical policy redesign Social Security solvency horizon: About 12 or 13 years - Episode note on financial trouble Longevity petition age range: 50 to 65 - Scott argues policy should focus here before raising pension age Social Security age change linked to health: Healthy life expectancy measure - Scott proposes indexing retirement age to healthspan

Pivotal Quotes: "One of the great achievements of the 20th century is to produce an aging society." — Andrew Scott: Scott reframes aging as a success, not a failure "Ageism is that weird prejudice against your future self." — Andrew Scott: On societal bias against older adults and older workers "The reason I started the company was to get the first drug FDA approved for Lifespan and HealthSpan extension." — Selene Hollywa: Loyal CEO on using dog drugs as a pathway to human longevity medicine

Implications: Listeners are urged to rethink aging as an expanding, healthier life stage that requires new policy, labor, and healthcare designs. The longevity market will likely grow, but real progress depends on prevention, regulation, and systems that support longer working lives.